NMDA receptor agonists reverse impaired psychomotor and cognitive functions associated with hippocampal Hbegf-deficiency in mice - Wikidata - awgldk - TriplyDB

NMDA receptor agonists reverse impaired psychomotor and cognitive functions associated with hippocampal Hbegf-deficiency in mice

NMDA receptor agonists reverse impaired psychomotor and cognitive functions associated with hippocampal Hbegf-deficiency in mice

http://www.wikidata.org/entity/Q27300850

about

Transethnic genome-wide scan identifies novel Alzheimer's disease loci.Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis.Prothymosin alpha-deficiency enhances anxiety-like behaviors and impairs learning/memory functions and neurogenesis.

P2860

Q40342077-3C845038-5419-45E7-9E79-07F0142203E6 Q42419288-F698ADDB-2549-4A99-8B3E-83D59182B8F3 Q47350210-BD268C5E-1ACF-4ED2-9E9D-0E648D957A82

P2860

NMDA receptor agonists reverse impaired psychomotor and cognitive functions associated with hippocampal Hbegf-deficiency in mice

http://www.wikidata.org/entity/Q27300850

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

NMDA receptor agonists reverse ...... ampal Hbegf-deficiency in mice

@ast

NMDA receptor agonists reverse ...... ampal Hbegf-deficiency in mice

@en

NMDA receptor agonists reverse ...... ampal Hbegf-deficiency in mice

@nl

type

label

NMDA receptor agonists reverse ...... ampal Hbegf-deficiency in mice

@ast

NMDA receptor agonists reverse ...... ampal Hbegf-deficiency in mice

@en

NMDA receptor agonists reverse ...... ampal Hbegf-deficiency in mice

@nl

prefLabel

NMDA receptor agonists reverse ...... ampal Hbegf-deficiency in mice

@ast

NMDA receptor agonists reverse ...... ampal Hbegf-deficiency in mice

@en

NMDA receptor agonists reverse ...... ampal Hbegf-deficiency in mice

@nl

P1433

Q27300850-117A887E-70C8-41EB-950D-0AFC7EAE9646

P1476

Q27300850-FB6DB5FA-311C-469B-82AD-91FD85C48F21

P2093

Q27300850-373530D6-B02F-4509-BB7E-44E241B3721C

Q27300850-72AEE2EE-7CBA-4DA9-AC1D-72FA3993C765

Q27300850-73ED9C9C-C024-4DF8-83E4-93FA35A13715

Q27300850-CA35A549-1980-4155-91E3-3238614E61B7

Q27300850-CFCB3B0C-B7FB-42CF-A604-3267244F4B92

P2860

Q27300850-08A86C76-7838-4791-97A4-B11E78F86FB6

Q27300850-0C28E493-0A38-45D5-BB6E-0EFB1FCB658D

Q27300850-16D04729-D8BB-40F3-955B-96BF000065D7

Q27300850-1B2E28EE-FCDA-4A9E-8197-D40FCEE6623C

Q27300850-20823A91-03D1-49C8-9873-4077F020D7A4

Q27300850-20C4CB44-84AA-464D-98FC-28F92478BC4F

Q27300850-22642D0B-ECA3-49B9-8412-8C505AA0DC91

Q27300850-252F64A1-05F7-49A7-AED9-92E8166AD26B

Q27300850-28DF1663-C248-4001-8207-EB6CAD52D1A4

Q27300850-290A24A3-B53F-444C-AF9B-2EABF1D75268

P2888

Q27300850-948BD873-E0A5-4F2C-8FCC-9267E868F8C5

P304

Q27300850-4BD19B01-E9CE-435C-8E57-B4868FE91CBA

P31

Q27300850-1F71AB05-2467-4EC0-BB98-69BF6C3C7EB9

P3181

Q27300850-FD910410-13B9-4254-BAF5-6377D3614A45

P356

Q27300850-F80A136E-09C1-4F5F-998F-264A61FF25E0

P407

Q27300850-6A23A77E-C6F8-478F-BAA6-A2A6DACCD827

P433

Q27300850-7AA9825F-2D4D-4904-AA6A-4D4DD9085FE4

P478

Q27300850-265A70E4-4A63-47A9-8163-827CEEE3949E

P577

Q27300850-08453017-1164-4525-9B8C-B9AC17D65558

P5875

Q27300850-7A93B84D-C797-431A-BA19-6C4E009C43CE

P6179

Q27300850-93E755AB-68B1-4741-BA04-17B5CEF05B4C

P698

Q27300850-580CA2D9-7B12-48DA-9163-41C0B55EBA1E

P932

Q27300850-5505499A-2662-4132-B03F-38240D82ED5D

P3181

P356

S13041-015-0176-0

P1433

Molecular Brain

P1476

NMDA receptor agonists reverse ...... ampal Hbegf-deficiency in mice

@en

P2093

Hiroshi Ueda

http://www.w3.org/2001/XMLSchema#string

Kazuyuki Shinohara

http://www.w3.org/2001/XMLSchema#string

Keita Sasaki

http://www.w3.org/2001/XMLSchema#string

Mutsumi Ueda

http://www.w3.org/2001/XMLSchema#string

Olaposi Idowu Omotuyi

http://www.w3.org/2001/XMLSchema#string

P2860

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation

Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments.

Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations

MAM: more than just a housekeeper

The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses

Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior.

Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core

Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses

Neurobiology of tourette syndrome: current status and need for further investigation

P2888

s13041-015-0176-0

P304

83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4530639

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S13041-015-0176-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285781952

http://www.w3.org/2001/XMLSchema#string

P6179

1043731009

http://www.w3.org/2001/XMLSchema#string

P698

26637193

http://www.w3.org/2001/XMLSchema#string

P932

4670538

http://www.w3.org/2001/XMLSchema#string